Efficacy and Safety of Isatuximab Combination Therapy in Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials.

Cancers (Basel) · 2025 · PMC12606759 · PMID 41228289

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the high-risk RRMM subgroup, a trend towards improved PFS was observed (HR = 0.70; 95% CI, 0.45–1.08; p = 0.107), although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.